English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 27 July 2020, 17:26 HKT/SGT
Share:
Singamas Advances Development of Custom-made Specialised Containers
Mobile PCR Lab Specially Developed for COVID-19 Testing
Delivered to Shanghai Pudong Airport for Arrival Testing

HONG KONG, July 27, 2020 - (ACN Newswire) - World-leading container manufacturer and logistics services provider Singamas Container Holdings Limited ("Singamas" / the "Group") (stock code: 716) has announced today that it has delivered a mobile Polymerase Chain Reaction ("PCR") laboratory for COVID-19 testing to the Shanghai Pudong Airport on 8 July 2020. The mobile laboratory can handle a maximum of 1,500 specimens a day. It consists of three functional rooms including the reagent preparation room, specimen processing room and PCR test room. Arrival testing will be commenced this week.


The mobile PCR laboratory has been developed by the Group's in-house R&D team located in Shanghai, the PRC, together with experts from the renowned Chinese Academy of Sciences and China Customs. Engineers from the Group's R&D team are dedicated to the research and development of advanced customised specialised containers meeting the needs of society as well as the demands from customers around the world. Apart from specialised transportation-focused containers, the Group's R&D team has been developing containers for use in a wide range of areas including but not limited to power generation, energy storage, data centres, housing and hotel, pressurized ex-proof, breeding and farming, as well as for scientific and medical applications.

Mr. Teo Siong Seng, Chairman of Singamas, said: "We are very excited about the development of the mobile PCR laboratory for the Shanghai Pudong Airport, and would like to thank the local government for entrusting us with this important responsibility for the city. As Singamas' specialised containers business develops, we are fascinated that when combined with modern technology, our products can be developed for diverse segments with diverse needs. With the support of our dedicated R&D team, superb manufacturing skills, and the trust and confidence of our customers, we have already developed over 1,000 types of specialised products to date. Moving forward, we are well-equipped to strengthen our product innovation and offer a comprehensive range of products to satisfy the specific needs of our community."

About Singamas Container Holdings Limited
Singamas is one of the world's major container manufacturers and logistics services providers. Its manufacturing business covers container factories located in Mainland China that focus on the manufacturing, R&D and sale of dry freight and specialised containers. Its logistics operations include container depots located in key locations in Mainland China and in Hong Kong, as well as a logistics company in Xiamen. Riding on its comprehensive investment strategies, the Group is consolidating its market leadership in the global container industry. For details, please visit: www.singamas.com.



Topic: Press release summary Sectors: Daily Finance, Daily News
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
TIS Appoints New CEO to Accelerate Global Growth  
Jan 26, 2026 20:00 HKT/SGT
Focus Graphite Announces Allowance of Canadian Patent for Silicon-Enhanced Graphite Anode Materials  
Jan 26, 2026 18:29 HKT/SGT
Fujitsu launches new platform enabling autonomous operation of generative AI optimized for in-house applications in a dedicated environment  
Monday, January 26, 2026 12:30:00 PM
Mitsubishi Heavy Industries and Mitsubishi Electric Invest in Japan LEO Shachu, a Space Venture Established by Mitsui & Co.  
Monday, January 26, 2026 12:24:00 PM
CaoCao Inc. Ushers in China's Fully Purpose-Built Robotaxi Era, Aims to Deploy 100,000 Robotaxis by 2030  
Monday, January 26, 2026 10:51:00 AM
FDA Accepts LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review  
Monday, January 26, 2026 10:37:00 AM
Fujitsu to support Mizuho Financial Group's human capital disclosure with a non-financial information collection and disclosure support service  
Monday, January 26, 2026 9:45:00 AM
Masar Destination Achieves LEED for Communities Gold Certification  
Jan 24, 2026 08:00 HKT/SGT
Sir Ivan Releases "Love Is The Piece"  
Jan 24, 2026 07:00 HKT/SGT
Open World Launches Saudi Arabia's First RWA Tokenization Center of Excellence to Advance Vision 2030 Digital Economy Goals  
Jan 23, 2026 23:00 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575